Wolf Man has come howling into theatres and this update of the classic horror story has made quite a few changes to stand ...

It was their highest score in Test cricket in Asia. Mitchell Starc, Matthew Kuhnemann and Nathan Lyon took one wicket each to end the day as Sri Lanka are still trailing by 610 runs with Dinesh ...

Positive News is the media brand for rigorous journalism about what’s going right. We report socially relevant and uplifting stories of progress – ranging from the global boom in renewable energy to ...

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target increased by Wells Fargo & Company from $133.00 to $136.00 in a research note issued on Thursday,Benzinga reports.

Abbott Laboratories posted lower-than-expected sales in its latest quarter, dented in part by diminished demand for Covid-19 testing-related products. The healthcare-products manufacturer logged ...

Excluding COVID-19 testing-related sales, growth in Rapid Diagnostics was driven by strong demand for Abbott’s portfolio of respiratory disease tests. Guidance: Abbott projects full-year 2025 ...

NEW YORK — Abbott escaped the COVID-19 "sales decline cloud" in 2024 and is prepared to deliver "another ... A large portion of the firm's diagnostics business is hospital-based testing, and the firm ...

From left: 'Abbott Elementary's William Stanford Davis, Lisa Ann Walter, Tyler James Williams, Quinta Brunson (seated) Sheryl Lee Ralph, Chris Perfetti and Janelle James ABC It’s become an ...

In 2020, the U.S. Centers for Disease Control and Prevention confirmed the United States' first known case of novel coronavirus -- what would later come to be known as COVID-19. In 2021 ...

For fourth-quarter fiscal 2024, Abbott projects non-GAAP earnings between ... expected to have gained from the continued expansion of test menus and capitalized on the growing demand for ...

For the week ending on Jan. 11, the COVID test positivity rate was 6.6%, slightly lower than the week prior. Emergency room visits with a positive COVID diagnosis were up from 0.9% to 1.3%.